SE319577B - - Google Patents
Info
- Publication number
- SE319577B SE319577B SE303166A SE303166A SE319577B SE 319577 B SE319577 B SE 319577B SE 303166 A SE303166 A SE 303166A SE 303166 A SE303166 A SE 303166A SE 319577 B SE319577 B SE 319577B
- Authority
- SE
- Sweden
- Prior art keywords
- chlormethiazole
- march
- stabilized
- composition
- mixture
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
1,147,731. Stabilized chlormethiazole compositions. ASTRA A.B. 1 March, 1967 [8 March, 1966], No. 9762/67. Heading A5B. A stabilized pharmaceutical composition comprising chlormethiazole is produced by forming an intimate mixture of chlormethiazole and a non-polar, non-toxic carrier selected from peanut oil, oleic acid, stearyl alcohol, stearic acid and mixtures of these carriers, in which mixture the amount of chlormethiazole is 20-85 percent by weight, based on the total weight of chlormethiazole and carrier. The composition may be in the form of a dosage unit comprising the above composition enclosed in a capsule of a watersoluble pharmaceutically acceptable solid material, e.g. gelatin.
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE303166A SE319577B (en) | 1966-03-08 | 1966-03-08 | |
NL6702002A NL156921B (en) | 1966-03-08 | 1967-02-09 | PROCESS FOR THE PREPARATION OF A THERAPEUTIC PREPARATION CONTAINING AS THE ACTIVE INGREDIENT 4-METHYL-5- (2'-CHLORETHYL) -THIA SOLE AND FORMED THERAPEUTIC PREPARED UNDER THIS PROCESS. |
DE1967A0054844 DE1617286B1 (en) | 1966-03-08 | 1967-02-09 | Medicinal product based on 4-methyl-5- (2'-chloroethyl) -thiazole |
BE693977D BE693977A (en) | 1966-03-08 | 1967-02-13 | |
AT151867A AT266126B (en) | 1966-03-08 | 1967-02-16 | Process for the stabilization of 4-methyl-5- (2'-chloroethyl) -thiazole |
GB976267A GB1147731A (en) | 1966-03-08 | 1967-03-01 | Improvements relating to the stabilization of chlormethiazole |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE303166A SE319577B (en) | 1966-03-08 | 1966-03-08 |
Publications (1)
Publication Number | Publication Date |
---|---|
SE319577B true SE319577B (en) | 1970-01-19 |
Family
ID=20261249
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE303166A SE319577B (en) | 1966-03-08 | 1966-03-08 |
Country Status (6)
Country | Link |
---|---|
AT (1) | AT266126B (en) |
BE (1) | BE693977A (en) |
DE (1) | DE1617286B1 (en) |
GB (1) | GB1147731A (en) |
NL (1) | NL156921B (en) |
SE (1) | SE319577B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AT358530B (en) * | 1978-04-25 | 1980-09-10 | Plc Pharma Licences | STABILIZATION PROCEDURE |
-
1966
- 1966-03-08 SE SE303166A patent/SE319577B/xx unknown
-
1967
- 1967-02-09 DE DE1967A0054844 patent/DE1617286B1/en active Pending
- 1967-02-09 NL NL6702002A patent/NL156921B/en not_active IP Right Cessation
- 1967-02-13 BE BE693977D patent/BE693977A/xx not_active IP Right Cessation
- 1967-02-16 AT AT151867A patent/AT266126B/en active
- 1967-03-01 GB GB976267A patent/GB1147731A/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
AT266126B (en) | 1968-11-11 |
BE693977A (en) | 1967-08-14 |
DE1617286B1 (en) | 1971-05-27 |
NL6702002A (en) | 1967-09-11 |
NL156921B (en) | 1978-06-15 |
GB1147731A (en) | 1969-04-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT71724A (en) | Process for the preparation of new optically active 1,4-dihidropyridine derivatives having anti-hypertensive and vassodi lator effect and of pharmaceutical compositions containing thern | |
SE8303531D0 (en) | PHARMACEUTICAL COMPOSITION | |
PT81039A (en) | Process for preparing pellet formulations | |
IL60326A0 (en) | Pharmaceutical compositions for parenteral administration of fatsolbule active substances | |
DE3665668D1 (en) | Pharmaceutical granulate containing ambroxol or bromohexine | |
SE319577B (en) | ||
JPS57109721A (en) | Carcinostatic agent | |
JPS52108028A (en) | Remedies for dysacousis | |
IL45136A0 (en) | Process for the preparation of 3-(0,0-diethyldithiophosphorylmethyl)-6-chloro-benzoxazolone and insecticidal and acaricidal compositions containing same | |
ES8102096A1 (en) | Derivatives of 3,4,5-trihydroxypiperidine, processes for their preparation, and their use as medicines and in animal food. | |
GB1442159A (en) | Pharmaceutical compositions containing paracetamol | |
JPS51120888A (en) | Pouching and packing device for powdered material | |
ES485992A1 (en) | Fungicidal compositions, process for their preparation and their application. | |
JPS54151925A (en) | Nn*1**methoxycarbonylethyl**nn*n**n** disubstituted hydrazinoacetyl**aniline derivative*its manufacture and fungicidal composition containing it as active component | |
JPS525769A (en) | Preparation of 3-substituted pyrolidine derivatives | |
GB1294538A (en) | Pharmaceutical compositions | |
JPS51136886A (en) | New biologica lly active substance, ml-236c, and its preparation | |
JPS51131847A (en) | Process for preparation of 2,2'- dithiobisbenzamide compounds | |
GB992222A (en) | Hypoglycemic compositions containing acyl disulphides and their esters | |
JPS5668611A (en) | Novel antiallergic agent | |
GB1446237A (en) | Pharmaceutical preparations containing pyrazolones | |
JPS5640607A (en) | Drug composition | |
JPS5498339A (en) | Carcinostatic agent | |
ES347270A1 (en) | Novel Benzodiazepines and process for their Manufacture | |
JPS51130786A (en) | Fuel assembly |